Aclaris Therapeutics
Total Raised
$82MInvestors Count
9Deal Terms
3Funding, Valuation & Revenue
5 Fundings
Aclaris Therapeutics has raised $82M over 5 rounds.
Aclaris Therapeutics's latest funding round was a IPO for $55M on October 7, 2015.
Aclaris Therapeutics's latest post-money valuation is from October 2015.
Sign up for a free demo to see Aclaris Therapeutics's valuations in October 2015 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
10/7/2015 | IPO | $55M | 1 | |||
9/10/2015 | Series C | |||||
10/2/2014 | Series B | |||||
10/24/2012 | Series A | |||||
Spinoff / Spinout |
Date | 10/7/2015 | 9/10/2015 | 10/2/2014 | 10/24/2012 | |
|---|---|---|---|---|---|
Round | IPO | Series C | Series B | Series A | Spinoff / Spinout |
Amount | $55M | ||||
Investors | |||||
Valuation | |||||
Revenue | |||||
Sources | 1 |
Aclaris Therapeutics Deal Terms
3 Deal Terms
Aclaris Therapeutics's deal structure is available for 3 funding rounds, including their IPO from October 07, 2015.
Round | IPO | Series B | Series A |
|---|---|---|---|
Funding Date | |||
Pre-Money Valuation | |||
Post-Money Valuation | |||
Amount Raised | |||
Shares Authorized | |||
Issuance Price | |||
Dividend Rate | |||
Liquidation Preferences | |||
Liquidation Price | |||
Participation | |||
Conversion Price | |||
Anti Dilution | |||
General Voting | |||
Board Voting | |||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IPO | |||||||||||||||
Series B | |||||||||||||||
Series A |
Aclaris Therapeutics Investors
9 Investors
Aclaris Therapeutics has 9 investors. Vivo Capital invested in Aclaris Therapeutics's Series C funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
10/24/2012 | 9/10/2015 | 3 Series A, Series B (2014), Series C (2015) | Venture Capital | California | ||
Venture Capital | Massachusetts | |||||
Venture Capital | California | |||||
Hedge Fund | Maryland | |||||
Asset/Investment Management | Massachusetts |
First funding | 10/24/2012 | ||||
|---|---|---|---|---|---|
Last Funding | 9/10/2015 | ||||
Investor | |||||
Rounds | 3 Series A, Series B (2014), Series C (2015) | ||||
Board Seats | |||||
Type | Venture Capital | Venture Capital | Venture Capital | Hedge Fund | Asset/Investment Management |
Location | California | Massachusetts | California | Maryland | Massachusetts |
Aclaris Therapeutics Acquisitions
2 Acquisitions
Aclaris Therapeutics acquired 2 companies. Their latest acquisition was Confluence Life Sciences on August 08, 2017.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
8/8/2017 | Series B | $12.13M | Acquired | 4 | ||
3/29/2016 |
Date | 8/8/2017 | 3/29/2016 |
|---|---|---|
Investment Stage | Series B | |
Companies | ||
Valuation | ||
Total Funding | $12.13M | |
Note | Acquired | |
Sources | 4 |
Loading...